THRIVE registry of patients with urea cycle disorders, including real-world experience with ammonia-scavenging agents (sodium phenylbutyrate, glycerol phenylbutyrate and sodium benzoate)

Trial Profile

THRIVE registry of patients with urea cycle disorders, including real-world experience with ammonia-scavenging agents (sodium phenylbutyrate, glycerol phenylbutyrate and sodium benzoate)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2013

At a glance

  • Drugs Glycerol phenylbutyrate (Primary) ; Sodium phenylbutyrate (Primary) ; Sodium benzoate
  • Indications Hyperammonaemia; Inborn urea cycle disorders
  • Focus Therapeutic Use
  • Acronyms THRIVE
  • Most Recent Events

    • 08 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top